No Data
No Data
No Data
A quick look at the TaiMei medical technology (2576.HK) IPO.
On September 27, china's largest provider of digital solutions for life science research and development, taimei medical technology, officially launched its IPO, with a stock code of 2576. The company plans to globally issue 22.4166 million shares, including 2.2418 million shares for sale in Hong Kong, 20.1748 million shares for international sale, with an additional 15% over-allotment option; the IPO will run from September 27 to October 3, 2024, with the expected pricing date of October 4; the offer price will be HK$10.0-13.0 per share, with a trading unit of 200 shares, an entry fee of approximately HK$2,600, morgan stanley and china international capital corporation serving as underwriters; forecasted.
Taimedical Technology (2576.HK) officially launched its IPO, a new opportunity for technology investment in the low interest rate cycle.
On September 27, China's largest life science research and development digital solution provider, Taimei Medical Technology, officially launched its IPO with the stock code 2576. The company will end the IPO on October 3 and plans to be listed on October 8. The company will sell for up to 13.0 Hong Kong dollars per lot, with 200 shares per lot and an entrance fee of about 2,600 Hong Kong dollars. Morgan Stanley and China International Capital Corporation are the sponsors. At this time, it happens to be the beginning of an interest rate cut cycle. The Fed's interest rate cut will improve global liquidity conditions, and the Hong Kong stock market is sensitive to external liquidity changes, thus will directly benefit from the interest rate cuts. Along with the continuous improvement of Hong Kong stock liquidity.
【New Stock IPO】New stock IPO: TaiMei Medical Technology (02576) starts its IPO today with an entrance fee of HKD 2,626.22.
Golden Finance News | Tai Mei Medical Technology (02576) will be publicly offering 22.4166 million H shares for global sale from today until October 3rd, with 10% earmarked for public offering in Hong Kong and the remainder for international placement, along with an additional 15% over-allotment option. The offering price per share ranges from 10 to 13 Hong Kong dollars, with a board lot of 200 shares and an entry fee of 2,626.22 Hong Kong dollars. The shares will officially be listed on October 8 (Tuesday). Morgan Stanley and China International Capital Corporation are the joint sponsors. Based on the mid-price of 11.5 Hong Kong dollars, the net fundraising amount is 0.1857 billion Hong Kong dollars, with approximately 35% of the net proceeds intended for optimization purposes.
TaiMei Medical Technology will be listed on October 8th after its IPO from September 27th to October 3rd.
Tai Mei Medical Technology (02576) will launch its IPO from September 27, 2024 to October 3, 2024, intending to globally issue 22.4166 million H shares. 2.2418 million shares will be offered for public sale in Hong Kong, while 20.1748 million shares will be offered internationally. Additionally, there are 3.3624 million shares for overallotment and a 15% greenshoe option. The offer price per share is HK$10-13, with a board lot of 200 shares. It is expected that the H shares will begin trading on the Hong Kong Stock Exchange at 9:00 AM on October 8, 2024 (Tuesday).
No Data
No Data